Healthcare Triangle is trading 6.19% higher at $0.78 on September 25, 2026, with no new company-specific catalyst identified for the intraday rise.
- Its latest notable announcement was a September 23 non-binding LOI to pursue a Roboticom asset acquisition; the proposal is preliminary, not a confirmed transaction.
- Broader markets are higher, but the supplied index moves are modest and do not establish a direct reason for the stock’s gain.
- Shares fell 19.90% to $0.73 in the September 24 session.